デフォルト表紙
市場調査レポート
商品コード
1363281

バイオインフォマティクスの市場規模、シェア、動向分析レポート:製品別、用途別、地域別、セグメント予測、2023年~2030年

Bioinformatics Market Size, Share & Trends Analysis Report By Product (Bioinformatics Platforms, Bioinformatics Services), By Application (Genomics, Cheminformatics, Metabolomics, Proteomics), By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 77 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
バイオインフォマティクスの市場規模、シェア、動向分析レポート:製品別、用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年09月26日
発行: Grand View Research
ページ情報: 英文 77 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオインフォマティクス市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のバイオインフォマティクス市場は、2023年から2030年にかけて13.7%のCAGRを記録し、2030年までに285億米ドルに達する見込みです。

バイオ医薬品の臨床開発の開拓と3次元薬剤設計技術へのニーズの高まりが、今後5年間の市場成長を牽引すると予想されます。

さらに、バイオインフォマティクスツールと分析プラットフォームの開発と新しい技術の導入は、この市場の成長に大きな影響を与える要因になると予想されます。また、新規APIやバイオ医薬品の迅速な開発に対する需要の高まりも、この産業の成長を促進すると予想されます。

バイオインフォマティクス市場レポートハイライト

  • ゲノミクス応用分野が2022年に大きな収益シェアを占める。医薬品開発やシーケンススクリーニングにおける薬理ゲノミクスの需要の高まりと、大規模なゲノムデータの管理を目的とした技術進歩のイントロダクションが、この大きなシェアを占める主な要因です。
  • バイオコンテンツ管理分野は、2022年の売上高シェア39.6%で市場をリードしました。データベース管理におけるバイオインフォマティクスツールやソフトウェアの使用率が高いことが、大きなシェアを占める主な理由の1つです。
  • 北米が市場を独占し、2022年の売上シェアは43.6%でした。収益の大部分は米国とカナダからもたらされており、この地域にはトップクラスの研究機関、学術機関、バイオインフォマティクス企業が広く存在していることが要因となっています。
  • 様々な「-omics」関連分野における研究開発数の増加と、これらの研究から生成される大量の生物学的データの統合の必要性も、業界プレイヤーを、より高速で効率的で汎用性の高いバイオインフォマティクス・ソフトウェア兼プラットフォームの商業化に向けた開発に向かわせると予想されます。
  • バイオコンテンツ管理分野は、2022年の売上高シェア39.6%で市場をリードしました。データベース管理におけるバイオインフォマティクスツールやソフトウェアの使用率が高いことが、大きなシェアを占める主な要因の一つです。
  • さらに、シーケンス・構造解析プラットフォーム分野は、次世代シーケンサーの発展と全ゲノムエクソームシーケンスのコスト削減が期待されることから、予測期間中に20%以上のCAGRで最も速い成長が見込まれています。これらの要因は、今後5年間のこの市場全体の成長に大きなプラスの影響を与えると予想されます。
  • ケムインフォマティクス分野は予測期間中に大幅な拡大が見込まれており、バイオマーカーの発見と開発に対する需要の増加がこの成長期待の主な理由です。医薬品開発プロセスのコスト削減、新薬の市場導入期間の短縮、ケムインフォマティクスとドラッグデザインによる創薬の成功率の向上が、このセグメントの成長をさらに押し上げると予想されます。
  • プロテオミクス・アプリケーションは、近い将来かなりの研究開発投資を集め、予測期間中に有利な成長を遂げると予想されます。3次元薬剤開発技術の開発が、このセグメントの成長をさらに押し上げると期待されています。
  • 北米が市場を独占し、2022年の売上シェアは43.6%でした。収益の大部分は米国とカナダからもたらされており、同地域にはトップクラスの研究機関、学術機関、バイオインフォマティクス企業が広く存在することが要因となっています。分子生物学とゲノムシーケンスに関連する新しく革新的な技術の研究開発への投資の増加が、この地域の市場を押し上げると予想されます。
  • アジア太平洋地域は、予測期間中のCAGRが18.4%で、最も急成長する地域市場になる見込みです。熟練した訓練を受けたバイオインフォマティシャンの存在と、同地域のITセクターの力強い発展が見込まれることから、新興経済諸国へのアウトソーシングサービス提供能力が高まると予想されます。また、政府の支援政策も、予測期間中のこの地域の成長を促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 バイオインフォマティクス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • バイオインフォマティクス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 バイオインフォマティクス市場:製品別推定・動向分析

  • バイオインフォマティクス市場:重要なポイント
  • バイオインフォマティクス市場:製品動向と市場シェア分析、2022年と2030年
  • バイオインフォマティクスプラットフォーム
    • バイオインフォマティクスプラットフォーム市場推計・予測、2018年から2030年まで
    • 配列解析プラットフォーム
    • 配列操作プラットフォーム
    • 配列アライメントプラットフォーム
    • 構造・機能解析プラットフォーム
    • その他
  • バイオコンテンツ管理
    • バイオコンテンツ管理市場推計・予測、2018年から2030年まで
    • 汎用バイオコンテンツツール
    • 特殊なバイオコンテンツツール
  • バイオインフォマティクスサービス
    • バイオインフォマティクスサービス市場推計・予測、2018年から2030年まで
    • シーケンス
    • データ分析サービス
    • データベース管理サービス
    • その他のバイオインフォマティクスサービス

第5章 バイオインフォマティクス市場:用途別展望

  • バイオインフォマティクス市場:重要なポイント
  • バイオインフォマティクス市場:別の動きと市場シェア分析、2022年と2030年
  • ゲノミクス
  • 分子系統学
  • メタボロミクス
  • プロテオミクス
  • トランスクリプトミクス
  • ケマインフォマティクスと創薬
  • その他

第6章 バイオインフォマティクス市場:地域別展望

  • 地域別の見通し
  • 地域別のバイオインフォマティクス市場:重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • DNAnexus Inc.
    • Seven Bridges Genomics
    • BGI Group
    • Partek Inc.
    • Thermo Fisher Scientific
    • Qiagen
    • Agilent Technologies
    • Illumina
    • PerkinElmer
図表

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Abbreviations
  • Table 3 North America bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America bioinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe bioinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 13 UK bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Germany bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 16 Germany bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 17 France bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 18 France bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 24 Sweden bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Norway bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark bioinformatics market by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific bioinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 32 China bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 33 China bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 36 India bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 37 India bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 38 Australia bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 39 Australia bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 41 Thailand bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 42 South Korea bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 43 South Korea bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 46 Latin America bioinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 47 Brazil bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Mexico bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 55 South Africa bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE bioinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait bioinformatics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait bioinformatics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Bioinformatics: Market outlook
  • Fig. 9 Bioinformatics Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Bioinformatics market driver impact
  • Fig. 15 Bioinformatics market restraint impact
  • Fig. 16 Bioinformatics market strategic initiatives analysis
  • Fig. 17 Bioinformatics market: Product movement analysis
  • Fig. 18 Bioinformatics market: Product outlook and key takeaways
  • Fig. 19 Bioinformatics platform market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Sequence analysis platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Sequence manipulation platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Sequence alignment platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Structural and functional analysis platform market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Bioinformatics services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Database management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Data analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Biocontent management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Generalized biocontent market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Specialized biocontent market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Bioinformatics market: Application movement analysis
  • Fig. 34 Bioinformatics market: Application outlook and key takeaways
  • Fig. 35 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Molecular phylogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Metabolomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Transcriptomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Cheminformatics and drug designing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Global bioinformatics market: Regional movement analysis
  • Fig. 43 Global bioinformatics market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-008-8

Bioinformatics Market Growth & Trends:

The global bioinformatics market is expected to reach USD 28.5 billion by 2030, registering a CAGR of 13.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Growing clinical development of biopharmaceutical and increasing need for three-dimensional drug designing technology are expected to drive the market growth over the next five years.

Furthermore, the development of bioinformatics tools and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry.

Bioinformatics Market Report Highlights:

  • The genomics application segment accounted for a significant revenue share in 2022. Growing demand for pharmacogenomics in drug development and sequence screening and the introduction of technological advancements aimed at managing large sets of genomic data are key factors accounting for this large share.
  • The bio-content management segment led the market with a revenue share of 39.6% in 2022. High usage rates of bioinformatics tools and software in database management are one of the primary reasons attributed to its large share, as it efficiently provides easy data sharing with external databases and resources and promotes data integration.
  • North America dominated the market and accounted for a revenue share of 43.6% in 2022. The majority of the revenue is generated from the U.S. and Canada, driven by the extensive presence of top research organizations, academic institutions, and bioinformatics businesses in the region.
  • Growth in the number of research and development studies in various '-omics' related segments and the need for integration of the large amounts of biological data generated from these studies are also expected to encourage industry players to develop faster, more efficient, and versatile bioinformatics software cum platforms for commercialization.
  • The bio-content management segment led the market with a revenue share of 39.6% in 2022. High usage rates of bioinformatics tools and software in database management are one of the primary reasons attributed to its large share, as it efficiently provides easy data sharing with external databases and resources and promotes data integration.
  • Moreover, the sequence and structural analysis platform segment is expected to grow at the fastest CAGR of over 20% over the forecast period owing to the development of next-generation sequencing and expected reduction in the cost of whole genome exome sequencing. These factors are expected to have a significantly positive impact on the overall growth of this market in the next five years.
  • The cheminformatics segment is expected to expand substantially during the forecast period, wherein increasing demand for biomarker discovery and development is the primary reason for this expected growth. Cost reductions in the drug development process, reduced time for introducing a new drug in the market, and an increase in the success rate of drug discovery by cheminformatics and drug designing are expected to further boost this segment's growth.
  • Proteomic applications are expected to attract a considerable amount of R&D investment in the near future and witness lucrative growth over the forecast period. Developments in three-dimensional drug development technologies are further expected to boost the growth of this segment.
  • North America dominated the market and accounted for a revenue share of 43.6% in 2022. The majority of the revenue is generated from the U.S. and Canada, driven by the extensive presence of top research organizations, academic institutions, and bioinformatics businesses in the region. Increasing investments in the research & development of new and innovative technologies related to molecular biology and genome sequencing is expected to boost the regional market.
  • Asia Pacific is poised to be the fastest-growing regional market with a CAGR of 18.4% during the projection period. The presence of skilled and trained bioinformaticians and the expected strong development of the region's IT sector are anticipated to enhance the capability of providing outsourcing services to developed economies. Supportive government policies are also expected to drive the growth of this region over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Bioinformatics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Bioinformatics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Bioinformatics Market: Product Estimates & Trend Analysis

  • 4.1. Bioinformatics Market: Key Takeaways
  • 4.2. Bioinformatics Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bioinformatics Platforms
    • 4.3.1. Bioinformatics platforms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Sequence analysis platforms
      • 4.3.2.1. Sequence analysis platforms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Sequence manipulation platforms
      • 4.3.3.1. Sequence manipulation platforms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Sequence alignment platforms
      • 4.3.4.1. Sequence alignment platforms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Structural and functional analysis Platforms
      • 4.3.5.1. Structural and functional analysis platforms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Others
      • 4.3.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Bio-content Management
    • 4.4.1. Bio-content management market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Generalized Bio-content Tools
      • 4.4.2.1. Generalized Bio-content Tools market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Specialized Bio-content Tools
      • 4.4.3.1. Specialized Bio-content Tools market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Bioinformatics Services
    • 4.5.1. Bioinformatics services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Sequencing
      • 4.5.2.1. Sequencing services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Data analysis services
      • 4.5.3.1. Data analysis services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Database management services
      • 4.5.4.1. Database management services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Other bioinformatics services
      • 4.5.5.1. Other bioinformatics services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bioinformatics Market: Application Outlook

  • 5.1. Bioinformatics Market: Key Takeaways
  • 5.2. Bioinformatics Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Genomics
    • 5.3.1. Genomics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Molecular Phylogenetics
    • 5.4.1. Molecular phylogenetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Metabolomics
    • 5.5.1. Metabolomics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Proteomics
    • 5.6.1. Proteomics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Transcriptomics
    • 5.7.1. Transcriptomics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Cheminformatics and Drug Designing
    • 5.8.1. Cheminformatics and drug designing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Bioinformatics Market Regional Outlook

  • 6.1. Regional Outlook
  • 6.2. Bioinformatics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America Bioinformatics market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Bioinformatics market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada Bioinformatics market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. DNAnexus Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Seven Bridges Genomics
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. BGI Group
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Partek Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Thermo Fisher Scientific
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Qiagen
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Agilent Technologies
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Illumina
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. PerkinElmer
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives